Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells - Wikidata - awgldk - TriplyDB

Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells

Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells

http://www.wikidata.org/entity/Q35144394

about

Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Multifunctional polymeric micelles for delivery of drugs and siRNA.Intracellular delivery system for antibody-Peptide drug conjugates Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents.Dynamic intracellular delivery of antibiotics via pH-responsive polymersomes.Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.Neutral polymeric micelles for RNA delivery Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists.Application of living free radical polymerization for nucleic acid delivery.Immunoconjugates and long circulating systems: origins, current state of the art and future directions Novel antibody-based proteins for cancer immunotherapy.In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma.Polymeric 3D nano-architectures for transport and delivery of therapeutically relevant biomacromolecules.Oligonucleotide therapeutics: chemistry, delivery and clinical progress.Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.Embedded nanomicro syringe on chip for molecular therapy Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles.Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs

P2860

Q28391849-4F937306-F064-47C5-A1C2-F9B8183A0523 Q30438973-DE0E0C3C-0010-49F9-A19D-ACE031A7D6F8 Q35594851-3D529B92-E6A6-43E9-99FE-B20BA1F13B82 Q35751371-9D0487E2-0423-4903-97C8-4594085F8AB9 Q35751554-B5C839D2-11A0-40B0-8B65-1C06C1955778 Q36692593-F1AAF5BE-0CC3-4922-9FC8-4DC5000DCFDA Q36763827-3368176C-AB88-467C-8A4A-9DF611909D29 Q36962681-DD4388B9-38B2-467F-AA30-1B217E2304A7 Q37066113-7870DB1D-082A-42AA-941D-C7D67A645665 Q37975522-FB0AA158-6F40-408F-8A29-A495BBF6F09A Q38042256-2C8E5BA9-F10D-4406-B856-96D67AE91125 Q38161370-378B5ACC-0793-4B7C-A2A4-9318E4761C67 Q38253121-A96C78DF-76A2-4F43-B489-8344107E1C45 Q38555019-F636F6D5-AB1F-46F4-AD09-4ABF9A1FF73D Q38618638-94E5116E-F609-4AA3-9545-40B73F76D3F6 Q38782716-3B38756A-6C4A-44CD-870C-9C0D4DE644AE Q38848191-50C6D00C-2AA2-4145-A049-E0326D190C92 Q38952654-68E70BA4-8E1A-4B7A-B763-520D8A016FB0 Q39014347-2356A6F3-8F8A-47CF-915D-B568F5673840 Q39396009-66D15EA2-4D92-4E5B-9DDA-38D38836D59C Q41240553-C40958A6-A9E5-4D58-BCB5-16EB5DE1E3E3 Q48145247-2EE5A7C4-E9CD-43CC-9E5D-CBE6D702570F Q58910462-AB0C078A-7E90-42D8-9F45-BCD9B820448C

P2860

Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells

http://www.wikidata.org/entity/Q35144394

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@ast

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@en

type

label

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@ast

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@en

prefLabel

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@ast

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@en

P1433

Q35144394-01E1C3B9-BDEA-4D79-960F-00580A643C00

P1476

Q35144394-D9D5D9BE-CBF5-42CF-859E-45AF1A944258

P2093

Q35144394-019A27E0-F8F6-4B59-9782-030F9C07C84D

Q35144394-1C3928DB-4823-4D61-9822-299CAB9C91A6

Q35144394-33F649EC-BDA1-42D6-B3CE-E110EE48B6B6

Q35144394-3405A60F-2145-482D-BBFF-24C657F2F5AE

Q35144394-4660537C-457D-45C4-BDDE-D43CCC147F9E

Q35144394-4980FF12-FF58-44F1-9375-9015B90D4DB9

Q35144394-CE260E04-66E2-4AD6-8CEE-0AE366BBC33F

Q35144394-D2662EB4-F806-4830-BE20-25AF7C7B96DB

P2860

Q35144394-02E0704E-7AE0-4C56-9D90-593132955E7F

Q35144394-0928408A-3D8D-4E1A-8314-5ACD4402697B

Q35144394-138434D0-C117-40B4-9003-19C1FA3A4CEF

Q35144394-15630886-C959-428F-A0D6-BF70EAC3AD56

Q35144394-1630CC92-D084-47BE-B993-6FEC8F4951B7

Q35144394-1F4FBCB8-69D6-4160-96E5-64591A8F34BB

Q35144394-220B9079-1D7C-44DD-BB9F-15488F4F10F6

Q35144394-24C55C4C-76AE-412A-A0AC-C594BEC3341C

Q35144394-287F355B-9EEF-47A8-9646-4C17CAD3C7CB

Q35144394-4D2A61B1-D363-4E77-917E-97A4F58004EC

P304

Q35144394-B7B08525-8DD8-4EA4-8218-37CCC8DC3C71

P31

Q35144394-D6D45B01-712F-4765-AE5D-035DFD136D95

P356

Q35144394-C8CFA4E7-5F3D-4368-A585-9426FDC70213

P433

Q35144394-E49A0E1D-A916-4CE2-816A-8DE3CA3173AC

P478

Q35144394-84D30237-4B9E-4C49-983C-92A4F68F79DE

P577

Q35144394-B1BC457C-5BD1-417A-9264-A57A6755A20C

P5875

Q35144394-563DA8E9-CA43-48CE-95ED-7114FEF5E8CA

P698

Q35144394-A37B113B-5E1E-435E-AAEC-A4334F0A0322

P921

Q35144394-617E7EFE-0D22-4A9D-B3A0-942E1B97227C

Q35144394-72287406-2308-466E-822C-88885D907203

P932

Q35144394-A57B4435-F944-4EE2-95EE-6992284DE1B9

P356

P1433

Molecular Therapy

P1476

Anti-CD22 antibody targeting o ...... ne silencing in lymphoma cells

@en

P2093

Anthony J Convertine

http://www.w3.org/2001/XMLSchema#string

Fan Lee

http://www.w3.org/2001/XMLSchema#string

Garrett C Booth

http://www.w3.org/2001/XMLSchema#string

Geoffrey Y Berguig

http://www.w3.org/2001/XMLSchema#string

Maria C Palanca-Wessels

http://www.w3.org/2001/XMLSchema#string

Oliver W Press

http://www.w3.org/2001/XMLSchema#string

Patrick S Stayton

http://www.w3.org/2001/XMLSchema#string

Richelle Cutler-Strom

http://www.w3.org/2001/XMLSchema#string

P2860

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Cancer statistics, 2010

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Reduced antibody response to streptavidin through site-directed mutagenesis

Regulated portals of entry into the cell

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe

pH-responsive polymeric micelle carriers for siRNA drugs.

P304

1529-1537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.104

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51181033

http://www.w3.org/2001/XMLSchema#string

P698

21629223

http://www.w3.org/2001/XMLSchema#string

P921

P932

3149160

http://www.w3.org/2001/XMLSchema#string